Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 104 (3) , 516-523
- https://doi.org/10.1016/j.ygyno.2006.09.015
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (NSC 91-2311-B-110-011)
This publication has 32 references indexed in Scilit:
- Deregulated degradation of the cdk inhibitor p27 and malignant transformationSeminars in Cancer Biology, 2002
- Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinomaCancer Letters, 2002
- Skp2 is oncogenic and overexpressed in human cancersProceedings of the National Academy of Sciences, 2001
- A CDK-Independent Function of Mammalian Cks1Molecular Cell, 2001
- p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27Current Biology, 1999
- Prognostic significance of p27Kip1 expression in colorectal cancer: a clinico-pathological characterizationThe Journal of Pathology, 1999
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 -Deficient MiceCell, 1996
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995